|
1
|
Klein R, Peto T, Bird A and Vannewkirk MR:
The epidemiology of age-related macular degeneration. Am J
Ophthalmol. 137:486–495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson LV, Forest DL, Banna CD, et al:
Cell culture model that mimics drusen formation and triggers
complement activation associated with age-related macular
degeneration. Proc Natl Acad Sci USA. 108:18277–18282. 2011.
View Article : Google Scholar
|
|
3
|
Luibl V, Isas JM, Kayed R, Glabe CG,
Langen R and Chen J: Drusen deposits associated with aging and
age-related macular degeneration contain nonfibrillar amyloid
oligomers. J Clin Invest. 116:378–385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mullins RF, Russell SR, Anderson DH and
Hageman GS: Drusen associated with aging and age-related macular
degeneration contain proteins common to extracellular deposits
associated with atherosclerosis, elastosis, amyloidosis, and dense
deposit disease. FASEB J. 14:835–846. 2000.
|
|
5
|
Isas JM, Luibl V, Johnson LV, et al:
Soluble and mature amyloid fibrils in drusen deposits. Invest
Ophthalmol Vis Sci. 51:1304–1310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Ohno-Matsui K, Yoshida T, et al:
Amyloid-beta up-regulates complement factor B in retinal pigment
epithelial cells through cytokines released from recruited
macrophages/microglia: another mechanism of complement activation
in age-related macular degeneration. J Cell Physiol. 220:119–128.
2009. View Article : Google Scholar
|
|
7
|
Wang J, Ohno-Matsui K, Yoshida T, et al:
Altered function of factor I caused by amyloid beta: implication
for pathogenesis of age-related macular degeneration from drusen. J
Immunol. 181:712–720. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurji KH, Cui JZ, Lin T, et al: Microarray
analysis identifies changes in inflammatory gene expression in
response to amyloid-beta stimulation of cultured human retinal
pigment epithelial cells. Invest Ophthalmol Vis Sci. 51:1151–1163.
2010. View Article : Google Scholar
|
|
9
|
Streilein JW: Immune privilege as the
result of local tissue barriers and immunosuppressive
microenvironments. Curr Opin Immunol. 5:428–432. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jo DH and Kim JH and Kim JH: How to
overcome retinal neuropathy: the fight against angiogenesis-related
blindness. Arch Pharm Res. 33:1557–1565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cunha-Vaz J, Bernardes R and Lobo C:
Blood-retinal barrier. Eur J Ophthalmol. 21:3–9. 2010. View Article : Google Scholar
|
|
12
|
Bailey TA, Kanuga N, Romero IA, Greenwood
J, Luthert PJ and Cheetham ME: Oxidative stress affects the
junctional integrity of retinal pigment epithelial cells. Invest
Ophthalmol Vis Sci. 45:675–684. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng S, Gan G, Rao VS, Adelman RA and
Rizzolo LJ: Effects of proinflammatory cytokines on the claudin-19
rich tight junctions of human retinal pigment epithelium. Invest
Ophthalmol Vis Sci. 53:5016–5028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Jin X, Liu KJ and Liu W: Matrix
metalloproteinase-2-mediated occludin degradation and
caveolin-1-mediated claudin-5 redistribution contribute to
blood-brain barrier damage in early ischemic stroke stage. J
Neurosci. 32:3044–3057. 2012. View Article : Google Scholar
|
|
15
|
Martins T, Baptista S, Gonçalves J, et al:
Methamphetamine transiently increases the blood-brain barrier
permeability in the hippocampus: role of tight junction proteins
and matrix metalloproteinase-9. Brain Res. 1411:28–40. 2011.
|
|
16
|
Bruban J, Glotin AL, Dinet V, et al:
Amyloid-beta(1–42) alters structure and function of retinal
pigmented epithelial cells. Aging Cell. 8:162–177. 2009.
|
|
17
|
Maminishkis A, Chen S, Jalickee S, et al:
Confluent monolayers of cultured human fetal retinal pigment
epithelium exhibit morphology and physiology of native tissue.
Invest Ophthalmol Vis Sci. 47:3612–3624. 2006. View Article : Google Scholar
|
|
18
|
Suzuki T, Yoshinaga N and Tanabe S:
Interleukin-6 (IL-6) regulates claudin-2 expression and tight
junction permeability in intestinal epithelium. J Biol Chem.
286:31263–31271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng S, Cen J, Huang Y, et al: Matrix
metalloproteinase-2 and -9 secreted by leukemic cells increase the
permeability of blood-brain barrier by disrupting tight junction
proteins. PLoS One. 6:e205992011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bauer AT, Bürgers HF, Rabie T and Marti
HH: Matrix metalloproteinase-9 mediates hypoxia-induced vascular
leakage in the brain via tight junction rearrangement. J Cereb
Blood Flow Metab. 30:837–848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manicone AM and McGuire JK: Matrix
metalloproteinases as modulators of inflammation. Semin Cell Dev
Biol. 19:34–41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jonas JB, Tao Y, Neumaier M and Findeisen
P: Cytokine concentration in aqueous humour of eyes with exudative
age-related macular degeneration. Acta Ophthalmol. 90:e381–e388.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ecker SM, Pfahler SM, Hines JC, Lovelace
AS and Glaser BM: Sequential in-office vitreous aspirates
demonstrate vitreous matrix metalloproteinase 9 levels correlate
with the amount of subretinal fluid in eyes with wet age-related
macular degeneration. Mol Vis. 18:1658–1667. 2012.
|
|
24
|
Jeong S, Ledee DR, Gordon GM, et al:
Interaction of clusterin and matrix metalloproteinase-9 and its
implication for epithelial homeostasis and inflammation. Am J
Pathol. 180:2028–2039. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huet E, Vallée B, Delbé J, et al: EMMPRIN
modulates epithelial barrier function through a MMP-mediated
occludin cleavage: implications in dry eye disease. Am J Pathol.
179:1278–1286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pflugfelder SC, Farley W, Luo L, et al:
Matrix metalloproteinase-9 knockout confers resistance to corneal
epithelial barrier disruption in experimental dry eye. Am J Pathol.
166:61–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kayed R, Head E, Thompson JL, et al:
Common structure of soluble amyloid oligomers implies common
mechanism of pathogenesis. Science. 300:486–489. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Giebel SJ, Menicucci G, McGuire PG and Das
A: Matrix metalloproteinases in early diabetic retinopathy and
their role in alteration of the blood-retinal barrier. Lab Invest.
85:597–607. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chau KY, Sivaprasad S, Patel N, Donaldson
TA, Luthert PJ and Chong NV: Plasma levels of matrix
metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular
degeneration. Eye. 22:855–859. 2008. View Article : Google Scholar
|
|
30
|
Chen W, Stambolian D, Edwards AO, et al:
Genetic variants near TIMP3 and high-density lipoprotein-associated
loci influence susceptibility to age-related macular degeneration.
Proc Natl Acad Sci USA. 107:7401–7406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Balda MS, Gonzalez-Mariscal L, Contreras
RG, et al: Assembly and sealing of tight junctions: possible
participation of G-proteins, phospholipase C, protein kinase C and
calmodulin. J Membr Biol. 122:193–202. 1991. View Article : Google Scholar
|
|
32
|
Bandyopadhyay M and Rohrer B: Matrix
metalloproteinase activity creates pro-angiogenic environment in
primary human retinal pigment epithelial cells exposed to
complement. Invest Ophthalmol Vis Sci. 53:1953–1961. 2012.
View Article : Google Scholar
|
|
33
|
Kook SY, Hong HS, Moon M, Ha CM, Chang S
and Mook-Jung I: Aβ1–42-RAGE interaction disrupts tight
junctions of the blood-brain barrier via
Ca2+-calcineurin signaling. J Neurosci. 32:8845–8854.
2012.
|
|
34
|
Thibault O, Gant JC and Landfield PW:
Expansion of the calcium hypothesis of brain aging and Alzheimer’s
disease: minding the store. Aging Cell. 6:307–317. 2007.PubMed/NCBI
|
|
35
|
Grolla AA, Fakhfouri G, Balzaretti G, et
al: Aβ leads to Ca2+ signaling alterations and
transcriptional changes in glial cells. Neurobiol Aging.
34:511–522. 2013.
|
|
36
|
Kuchibhotla KV, Lattarulo CR, Hyman BT and
Bacskai BJ: Synchronous hyperactivity and intercellular calcium
waves in astrocytes in Alzheimer mice. Science. 323:1211–1215.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kobayashi T, Hattori S, Nagai Y and Tajima
S: Differential regulation of the secretions of matrix
metalloproteinase-9 and tissue inhibitor of metalloproteinases-1
from human keratinocytes in culture. IUBMB Life. 50:221–226. 2000.
View Article : Google Scholar
|
